文献速递胃肠外科围术期管理与 ERAS

胃旁路术与袖状胃切除术:瑞典、挪威与荷兰国家质量登记中47,101例初次手术的患者选择与短期结局

Gastric Bypass Versus Sleeve Gastrectomy: Patient Selection and Short-term Outcome of 47,101 Primary Operations From the Swedish, Norwegian, and Dutch National Quality Registries.
PubMed 文献 · Ann Surg · 2020-01-01

该研究基于瑞典、挪威和荷兰三国国家质量登记数据,比较Roux-en-Y胃旁路术(RYGB)与袖状胃切除术(SG)的患者选择与短期结局。共纳入47,101例初次手术,RYGB占70.1%,SG占29.9%。两种术式严重并发症与30天死亡率无差异,RYGB再入院率略高但1年减重效果与随访率更优。

要点

  • 两种术式严重并发症与30天死亡率无显著差异,RYGB再入院率略高。
  • RYGB术后1年总减重超过20%的患者比例更高,随访丢失率更低。

核心结论

  • RYGB与SG均安全,RYGB减重效果与随访率更优,代价是30天再入院率略高。

研究设计与样本

  • 基于瑞典、挪威和荷兰三国国家减重手术质量登记数据的观察性研究,共纳入47,101例初次手术,其中RYGB 33,029例(70.1%),SG 14,072例(29.9%)。

主要发现

  • 两种术式严重并发症发生率无显著差异(2.6% vs 2.4%,P = 0.382)。
  • 两种术式30天死亡率无显著差异(0.04% vs 0.03%,P = 0.821)。
  • RYGB再入院率高于SG(4.3% vs 3.4%,P < 0.001)。
  • 术后1年RYGB随访丢失率低于SG(12.1% vs 16.5%,P < 0.001),且总减重超过20%的患者比例更高(95.8% vs 84.6%,P < 0.001)。

关键数值与推荐

  • 严重并发症:RYGB 2.6%,SG 2.4%(P = 0.382)。
  • 30天死亡率:RYGB 0.04%,SG 0.03%(P = 0.821)。
  • 30天再入院率:RYGB 4.3%,SG 3.4%(P < 0.001)。
  • 1年总减重超过20%的比例:RYGB 95.8%,SG 84.6%(P < 0.001)。

临床怎么用

  • RYGB与SG均可作为安全的减重术式,选择时需权衡RYGB更优的减重效果与略高的再入院风险。
  • SG术后减重效果在不同医院间变异较大,应关注术式标准化与随访管理。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to compare the use and short-term outcome of Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) in Sweden, Norway, and the Netherlands. BACKGROUND: Although bariatric surgery is performed in high volumes worldwide, no consensus exists regarding the choice of bariatric procedure for specific groups of patients. METHODS: Data from 3 national registries for bariatric surgery were used. Patient selection, perioperative data (severe complications, mortality, and rate of readmissions within 30 days), and 1-year results (follow-up rate and weight loss) were studied. RESULTS: A total of 47,101 primary operations were registered, 33,029 (70.1%) RYGB and 14,072 (29.9%) SG. Patients receiving RYGB met international guidelines for having bariatric surgery more often than those receiving SG (91.9% vs 83,0%, P < 0.001). The 2 procedures did not differ in the rate of severe complications (2.6% vs 2.4%, P = 0.382), nor 30-day mortality (0.04% vs 0.03%, P = 0.821). Readmission rates were higher after RYGB (4.3% vs 3.4%, P < 0.001).One-year post surgery, less RYGB-patients were lost-to follow-up (12.1% vs 16.5%, P < 0.001) and RYGB resulted in a higher rate of patients with total weight loss of more than 20% (95.8% vs 84.6%, P < 0.001). While the weight-loss after RYGB was similar between hospitals, there was a great variation in weight loss after SG. CONCLUSION: This study reflects the pragmatic use and short-term outcome of RYGB and SG in 3 countries in North-Western Europe. Both procedures were safe, with RYGB having higher weight loss and follow-up rates at the cost of a slightly higher 30-day readmission rate.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Poelemeijer YQM, Liem RSL, Våge V, et al. Gastric Bypass Versus Sleeve Gastrectomy: Patient Selection and Short-term Outcome of 47,101 Primary Operations From the Swedish, Norwegian, and Dutch National Quality Registries. Ann Surg. 2020. PMID: 32675546. doi:10.1097/SLA.0000000000003279

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。